NOVONIX Ltd Files Form 6-K for May 2024

Ticker: NVNXF · Form: 6-K · Filed: May 17, 2024 · CIK: 1859795

Sentiment: neutral

Topics: sec-filing, 6-k, corporate-action

TL;DR

NOVONIX filed a 6-K, check Appendix 3H for security changes.

AI Summary

NOVONIX Ltd filed a Form 6-K on May 17, 2024, reporting its activities for May 2024. The filing includes Appendix 3H, which details changes in the company's securities. NOVONIX Limited is incorporated in Australia and its principal executive office is located in Brisbane.

Why It Matters

This filing provides an update on NOVONIX's corporate actions and securities, which is important for investors tracking the company's financial and operational status.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain significant new financial or operational information that would immediately alter risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public in its home country, files or makes public with a stock exchange, or distributes or makes public to its security holders.

What specific exhibit is mentioned in this 6-K filing?

This filing mentions Exhibit 99.1, which is Appendix 3H.

Where is NOVONIX Ltd's principal executive office located?

NOVONIX Ltd's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.

Does NOVONIX Ltd file its annual reports under Form 20-F or Form 40-F?

NOVONIX Ltd indicates that it files its annual reports under cover of Form 20-F.

What is the SIC code for NOVONIX Ltd?

The Standard Industrial Classification (SIC) code for NOVONIX Ltd is 3690, which corresponds to Miscellaneous Electrical Machinery, Equipment & Supplies.

Filing Stats: 210 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-05-16 20:15:16

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: May 16, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing